(G62.2) Polyneuropathy due to other toxic agents

More details coming soon

Icon
1 235 580 in individuals diagnosis polyneuropathy due to other toxic agents confirmed
Icon
17 948 deaths with diagnosis polyneuropathy due to other toxic agents
Icon
2% mortality rate associated with the disease polyneuropathy due to other toxic agents

Diagnosis polyneuropathy due to other toxic agents is diagnosed Men are 17.74% more likely than Women

727 384

Men receive the diagnosis polyneuropathy due to other toxic agents

10 340 (1.4 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
508 196

Women receive the diagnosis polyneuropathy due to other toxic agents

7 608 (1.5 %)

Died from this diagnosis.

Risk Group for the Disease polyneuropathy due to other toxic agents - Men aged 60-64 and Women aged 65-69

Icon
In Men diagnosis is most often set at age 0-95+
Icon
in in men, the disease manifests at any ageLess common in women the disease occurs at Age 0-5
Icon
In Women diagnosis is most often set at age 5-95+

Disease Features polyneuropathy due to other toxic agents

Icon
Absence or low individual and public risk
Icon

Polyneuropathy due to other toxic agents - what does this mean

Polyneuropathy due to other toxic agents is a disorder caused by exposure to certain toxins, such as certain industrial chemicals, insecticides, and heavy metals, that damage the peripheral nerves. this damage can cause numbness, tingling, burning, and weakness in the arms and legs and can affect the autonomic nervous system, leading to problems with blood pressure, heart rate, digestion, and bladder control.

What happens during the disease - polyneuropathy due to other toxic agents

Polyneuropathy due to other toxic agents is a condition in which the peripheral nerves become damaged from exposure to toxic agents. the damage is caused by the toxic agent disrupting the normal functioning of the nerves, leading to impaired nerve conduction and a decrease in nerve function. this can cause symptoms such as muscle weakness, numbness, and pain. in some cases, the damage may be permanent. treatment typically involves avoiding further exposure to the toxic agent and managing symptoms with medications and physical therapy.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination and medical history
  • Blood tests to check for toxins
  • Electromyography (EMG) to measure the electrical activity of muscles
  • Nerve conduction velocity (NCV) test to measure the speed of signals traveling along nerves
  • Imaging tests such as MRI or CT scans to look for signs of nerve damage
  • Lumbar puncture (spinal tap) to look for signs of inflammation or infection in the spinal cord or brain
  • Biopsy of nerve tissue to look for signs of inflammation or damage

Treatment and Medical Assistance

Main goal: Treating Polyneuropathy due to other toxic agents
  • Identifying and avoiding the toxic agents responsible for the Polyneuropathy
  • Managing the underlying cause of the Polyneuropathy
  • Managing the symptoms of the Polyneuropathy
  • Providing medications to reduce pain and inflammation
  • Providing physical therapy to improve mobility and strength
  • Providing occupational therapy to help with daily activities
  • Providing psychological support to help cope with the condition
  • Providing nutritional advice to improve overall health
  • Providing lifestyle modifications to reduce the risk of further complications
Icon
24 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Polyneuropathy due to other toxic agents - Prevention

The best way to prevent polyneuropathy due to other toxic agents is to avoid exposure to any known toxic agents. if this is not possible, then proper protective gear and safety measures should be taken to minimize the risk of exposure. additionally, regular check-ups and tests should be done to ensure that any signs of polyneuropathy are caught early and treated quickly.